Pro-Dex (PDEX) Competitors $28.40 +0.33 (+1.18%) Closing price 10/24/2025 04:00 PM EasternExtended Trading$28.34 -0.05 (-0.19%) As of 10/24/2025 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock PDEX vs. KIDS, SMLR, TMCI, DCTH, CARL, NPCE, DRTS, TCMD, RXST, and BWAYShould you be buying Pro-Dex stock or one of its competitors? The main competitors of Pro-Dex include OrthoPediatrics (KIDS), Semler Scientific (SMLR), Treace Medical Concepts (TMCI), Delcath Systems (DCTH), Carlsmed (CARL), NeuroPace (NPCE), Alpha Tau Medical (DRTS), Tactile Systems Technology (TCMD), RxSight (RXST), and Brainsway (BWAY). These companies are all part of the "medical equipment" industry. Pro-Dex vs. Its Competitors OrthoPediatrics Semler Scientific Treace Medical Concepts Delcath Systems Carlsmed NeuroPace Alpha Tau Medical Tactile Systems Technology RxSight Brainsway Pro-Dex (NASDAQ:PDEX) and OrthoPediatrics (NASDAQ:KIDS) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their institutional ownership, earnings, risk, media sentiment, profitability, dividends, analyst recommendations and valuation. Which has higher valuation and earnings, PDEX or KIDS? Pro-Dex has higher earnings, but lower revenue than OrthoPediatrics. OrthoPediatrics is trading at a lower price-to-earnings ratio than Pro-Dex, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPro-Dex$66.59M1.40$8.98M$2.7010.52OrthoPediatrics$204.73M2.09-$37.82M-$1.79-9.51 Is PDEX or KIDS more profitable? Pro-Dex has a net margin of 13.48% compared to OrthoPediatrics' net margin of -18.92%. Pro-Dex's return on equity of 26.67% beat OrthoPediatrics' return on equity.Company Net Margins Return on Equity Return on Assets Pro-Dex13.48% 26.67% 14.95% OrthoPediatrics -18.92%-6.36%-4.69% Which has more risk and volatility, PDEX or KIDS? Pro-Dex has a beta of -0.11, meaning that its share price is 111% less volatile than the S&P 500. Comparatively, OrthoPediatrics has a beta of 1.02, meaning that its share price is 2% more volatile than the S&P 500. Does the media favor PDEX or KIDS? In the previous week, OrthoPediatrics had 1 more articles in the media than Pro-Dex. MarketBeat recorded 4 mentions for OrthoPediatrics and 3 mentions for Pro-Dex. Pro-Dex's average media sentiment score of 0.63 beat OrthoPediatrics' score of 0.53 indicating that Pro-Dex is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Pro-Dex 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive OrthoPediatrics 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do insiders & institutionals have more ownership in PDEX or KIDS? 15.3% of Pro-Dex shares are owned by institutional investors. Comparatively, 69.1% of OrthoPediatrics shares are owned by institutional investors. 45.9% of Pro-Dex shares are owned by company insiders. Comparatively, 32.7% of OrthoPediatrics shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth. Do analysts prefer PDEX or KIDS? Pro-Dex presently has a consensus target price of $56.00, indicating a potential upside of 97.18%. OrthoPediatrics has a consensus target price of $26.29, indicating a potential upside of 54.35%. Given Pro-Dex's higher possible upside, equities research analysts plainly believe Pro-Dex is more favorable than OrthoPediatrics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Pro-Dex 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.50OrthoPediatrics 1 Sell rating(s) 1 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 2.67 SummaryPro-Dex beats OrthoPediatrics on 9 of the 16 factors compared between the two stocks. Get Pro-Dex News Delivered to You Automatically Sign up to receive the latest news and ratings for PDEX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding PDEX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PDEX vs. The Competition Export to ExcelMetricPro-DexMED/DENTAL IndustryMedical SectorNASDAQ ExchangeMarket Cap$93.15M$18.23B$6.21B$10.81BDividend YieldN/A1.64%5.72%4.80%P/E Ratio10.5218.2531.6030.98Price / Sales1.402.34595.06133.64Price / Cash9.0613.3237.2561.86Price / Book2.533.0312.056.61Net Income$8.98M$472.95M$3.34B$277.10M7 Day Performance8.31%2.53%1.94%2.57%1 Month Performance-16.45%-1.84%6.88%3.20%1 Year Performance-2.30%-10.08%56.06%33.22% Pro-Dex Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PDEXPro-Dex2.7629 of 5 stars$28.40+1.2%$56.00+97.2%-2.3%$93.15M$66.59M10.52140News CoverageUpcoming EarningsAnalyst ForecastKIDSOrthoPediatrics4.558 of 5 stars$17.51+7.4%$26.29+50.1%-33.7%$408.70M$204.73M-9.78200Upcoming EarningsAnalyst ForecastSMLRSemler Scientific3.5109 of 5 stars$26.33-1.8%$74.25+182.0%-12.6%$405.81M$56.29M10.84120Trending NewsAnalyst ForecastTMCITreace Medical Concepts2.1396 of 5 stars$6.00+2.0%$9.83+63.9%+46.5%$371.46M$209.36M-7.59250News CoveragePositive NewsAnalyst ForecastDCTHDelcath Systems2.694 of 5 stars$11.35+8.5%$24.50+115.9%-4.2%$365.90M$37.21M227.0060News CoverageAnalyst ForecastAnalyst RevisionGap DownCARLCarlsmedN/A$13.13+0.1%N/AN/A$348.74M$27.17M0.00100News CoverageShort Interest ↑NPCENeuroPace2.7596 of 5 stars$10.48+1.9%$16.60+58.4%+65.0%$340.08M$79.91M-12.48170Analyst ForecastDRTSAlpha Tau Medical2.6125 of 5 stars$3.93+4.0%$9.00+129.0%+92.3%$320.62MN/A-8.1980News CoverageAnalyst ForecastTCMDTactile Systems Technology3.8583 of 5 stars$14.30+0.6%$16.83+17.7%+6.3%$316.99M$292.98M23.061,037Analyst ForecastRXSTRxSight2.1593 of 5 stars$7.57+0.8%$10.00+32.1%-82.9%$307.28M$139.93M-9.46220Analyst ForecastBWAYBrainsway2.9461 of 5 stars$15.16+0.5%$18.00+18.7%+74.4%$286.58M$41.02M58.31120News Coverage Related Companies and Tools Related Companies KIDS Competitors SMLR Competitors TMCI Competitors DCTH Competitors CARL Competitors NPCE Competitors DRTS Competitors TCMD Competitors RXST Competitors BWAY Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:PDEX) was last updated on 10/26/2025 by MarketBeat.com Staff From Our PartnersU.S. Government Sparking Crypto RallyMissed Bitcoin when it was $100? You’re not alone. Crypto runs in cycles—and the next one is already underw...Crypto 101 Media | SponsoredIt’s Time to Buy “the NVIDIA of Quantum Computing”Yahoo Finance wrote that investing in quantum computing could... "Lead to life-changing returns... and make...Brownstone Research | SponsoredTrump’s new nightmare beginsPorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredBuy the dip? Here’s my #1 gold stock“The most obvious opportunity in gold stocks I’ve seen in my career” While everyone is distracted by gold’s...Golden Portfolio | SponsoredThe strategy that wins no matter where the market goesJoel and Adam have built a crypto trading system with a 93% win rate — even through volatile, sideways markets...Crypto Swap Profits | SponsoredOptions Pro Reveals His #1 Retirement Income TradeIf you want a way to generate consistent market income without chasing volatile AI stocks or complex crypto tr...Base Camp Trading | SponsoredElon Musk is on the lineElon Musk says November 6 could "affect the future of the world" Get ready for the biggest pivot in corpora...Altimetry | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pro-Dex, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Pro-Dex With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
